Bank of America’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $151M | Buy |
|
|||||
|
2025
Q1 | $116M | Buy |
|
|||||
|
2024
Q4 | $88.5M | Sell |
|
|||||
|
2024
Q3 | $107M | Buy |
|
|||||
|
2024
Q2 | $86.3M | Buy |
|
|||||
|
2024
Q1 | $58.7M | Buy |
|
|||||
|
2023
Q4 | $24.7M | Buy |
|
|||||
|
2023
Q3 | $23.1M | Buy |
|
|||||
|
2023
Q2 | $12.3M | Sell |
|
|||||
|
2023
Q1 | $20.1M | Buy |
|
|||||
|
2022
Q4 | $15.1M | Buy |
|
|||||
|
2022
Q3 | $12.4M | Sell |
|
|||||
|
2022
Q2 | $12.5M | Sell |
|
|||||
|
2022
Q1 | $16.5M | Sell |
|
|||||
|
2021
Q4 | $20.3M | Sell |
|
|||||
|
2021
Q3 | $28.3M | Buy |
|
|||||
|
2021
Q2 | $20.7M | Sell |
|
|||||
|
2021
Q1 | $33.6M | Buy |
|
|||||
|
2020
Q4 | $19.2M | Buy |
|
|||||
|
2020
Q3 | $15M | Buy |
|
|||||
|
2020
Q2 | $18.8M | Buy |
|
|||||
|
2020
Q1 | $13.3M | Buy |
|
|||||
|
2019
Q4 | $14.2M | Sell |
|
|||||
|
2019
Q3 | $11.5M | Buy |
|
|||||
|
2019
Q2 | $13.7M | Sell |
|
|||||
|
2019
Q1 | $106M | Sell |
|
|||||
|
2018
Q4 | $107M | Buy |
|
|||||
|
2018
Q3 | $126M | Buy |
|
|||||
|
2018
Q2 | $98.4M | Sell |
|
|||||
|
2018
Q1 | $72.4M | Sell |
|
|||||
|
2017
Q4 | $175M | Buy |
|
|||||
|
2017
Q3 | $56.6M | Sell |
|
|||||
|
2017
Q2 | $113M | Sell |
|
|||||
|
2017
Q1 | $139M | Sell |
|
|||||
|
2016
Q4 | $173M | Sell |
|
|||||
|
2016
Q3 | $318M | Sell |
|
|||||
|
2016
Q2 | $364M | Sell |
|
|||||
|
2016
Q1 | $414M | Sell |
|
|||||
|
2015
Q4 | $538M | Sell |
|
|||||
|
2015
Q3 | $480M | Buy |
|
|||||
|
2015
Q2 | $177M | Buy |
|
|||||
|
2015
Q1 | $157M | Sell |
|
|||||
|
2014
Q4 | $153M | Buy |
|
|||||
|
2014
Q3 | $97.1M | Sell |
|
|||||
|
2014
Q2 | $242M | Buy |
|
|||||
|
2014
Q1 | $120M | Sell |
|
|||||
|
2013
Q4 | $92.3M | Buy |
|
|||||
|
2013
Q3 | $67.8M | Sell |
|
|||||
|
2013
Q2 | $73.3M | Buy |
|